Rx Pricing Could Trigger HHS Risk Payments To Insurance Plans
This article was originally published in The Pink Sheet Daily
Executive Summary
Both drug manufacturers and insurers support changing risk adjustment model under Affordable Care Act; HHS plans white paper and stakeholder meeting in March.